Quick Answer
Dermata Therapeutics, Inc. reported Common Stock Shares Outstanding of 2.66 million shares for the year ending 2025.
- Dermata Therapeutics, Inc. showed an increase of +956.8% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Dermata Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 5 years of available data (2021 to 2025), Dermata Therapeutics, Inc.'s Common Stock Shares Outstanding has declined by 68.1%.
- Historical annual values: Fiscal year 2025: 2.66 million shares | Fiscal year 2024: 251,725 shares | Fiscal year 2023: 261,998 shares | Fiscal year 2022: 770,115 shares | Fiscal year 2021: 8.33 million shares.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: